Skip to content

Real world registration of Dahuang Lidan tablet in the treatment of nonalcoholic fatty liver disease

Real world registration of Dahuang Lidan tablet in the treatment of nonalcoholic fatty liver disease

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100051443
Enrollment
Unknown
Registered
2021-09-23
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonalcoholic fatty liver disease

Interventions

Observation group:None

Sponsors

Longhua Hospital Affiliated to Shanghai University of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of NAFLD in western medicine; 2. Aged 18 to 80 years; 3. Gender unlimited; 4. The subjects agreed to join the clinical study, voluntarily signed the informed consent form, and agreed to participate in the visit, examination and treatment according to the requirements of the research protocol.

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women; 2. Patients considered unsuitable by the investigator to participate in this study.

Design outcomes

Primary

MeasureTime frame
Proportion of patients whose ALT level returned to normal (= 30%;Changes of total cholesterol (TC) ratio before and after treatment and the proportion of patients who returned to normal (<= 5.17 mmol / L) after treatment;Changes of Traditional Chinese Medicine syndrome score before and after treatment;

Secondary

MeasureTime frame
Changes of liver imaging before and after treatment;

Countries

China

Contacts

Public ContactJi Guang

Longhua Hospital Affiliated to Shanghai University of traditional Chinese Medicine; Xinhua Hospital Affiliated to Medical College of Shanghai Jiaotong University

jg@shutcm.edu.cn+86 13816018198

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026